Structure of the C1 complex of complement.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
   Article
2. Reply to Mortensen et al.: The zymogen form of complement component C1.Proceedings of the National Academy of Sciences of the United States of America · 2018
   Article
3. Reply to Arlaud et al.: Structure of the C1 complex and the unbound C1rProceedings of the National Academy of Sciences of the United States of America · 2017
   Article

Corrections and comments

• Commented on by
  Reply to Arlaud et al.: Structure of the C1 complex and the unbound C1r2017
• Comment on
  Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.2017

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as